تداخلات سيفيكسيم

INVANZ is contraindicated in patients with known hypersensitivity to any component of this product or to other drugs in the same class or in patients who have demonstrated anaphylactic reactions to beta-lactams. (نشرة إرتابينيم، موانع الاستعمال)

CONTRAINDICATIONS The use of Ampicillin is contraindicated in individuals with a history of serious hypersensitivity reactions (e.g., anaphylaxis or Stevens-Johnson syndrome) to ampicillin or to other beta-lactam antibacterial drugs. (نشرة أمبيسيلين، موانع الاستعمال)

CONTRAINDICATIONS The use of UNASYN is contraindicated in individuals with a history of serious hypersensitivity reactions (e.g., anaphylaxis or Stevens-Johnson syndrome) to ampicillin, sulbactam or to other beta-lactam antibacterial drugs (e.g., penicillins and cephalosporins). (نشرة أمبيسيلين وسولباكتام، موانع الاستعمال)

AMOXIL is contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to AMOXIL or to other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins). (نشرة أموكسيسيلين، موانع الاستعمال)

History of a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to AUGMENTIN or to other beta‑lactams (e.g., penicillins or cephalosporins). (نشرة أموكسيسيلين وكلافولانات، موانع الاستعمال)

Hypersensitivity Reactions: Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving therapy with beta-lactams. (نشرة إيميبينيم وسيلاستاتين، التحذيرات والاحتياطات)

Piperacillin and Tazobactam for Injection and Sodium Chloride Injection is contraindicated in patients with a history of allergic reactions to any of the penicillins, cephalosporins, or betalactamase inhibitors. (نشرة بيبراسيلين وتازوباكتام، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

Contraindicated in patients with known allergy to cefixime or other cephalosporins. (نشرة سيفيكسيم، موانع الاستعمال)

WARNINGS Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving beta-lactam antibacterial drugs. (نشرة نافسيلين، التحذيرات)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (نشرة أزتريونام، التحذيرات والاحتياطات)

If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Drug Interactions When probenecid is used to elevate plasma concentrations of penicillin or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (نشرة بروبينيسيد، التداخلات الدوائية)

DRUG INTERACTIONS When probenecid is used to elevate plasma concentrations of penicillin, or other beta-lactams, or when such drugs are given to patients taking probenecid therapeutically, high plasma concentrations of the other drug may increase the incidence of adverse reactions associated with that drug. (نشرة بروبينيسيد وكولشيسين، التداخلات الدوائية)

Drug Interactions Protamine sulfate has been shown to be incompatible with certain antibiotics, including several of the cephalosporins and penicillins (see DOSAGE AND ADMINISTRATION ). (نشرة بروتامين، الاحتياطات)

If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Increased nephrotoxicity has been reported following concomitant administration of aminoglycoside antibiotics and cephalosporins. (نشرة جنتاميسين، التداخلات الدوائية)

Ethacrynic acid may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin antibiotics. (نشرة حمض الإيثاكرينيك، التداخلات الدوائية)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

If this product is to be given to penicillin-sensitive patients, caution should be exercised because cross hypersensitivity among beta-lactam antibacterial drugs has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Cephalosporin Furosemide can increase the risk of cephalosporin-induced nephrotoxicity even in the setting of minor or transient renal impairment. (نشرة فوروسيميد، التداخلات الدوائية)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Prothrombin time should be monitored in patients at risk and exogenous vitamin K administered as indicated. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Prothrombin time should be monitored in patients at risk and exogenous vitamin K administered as indicated. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Drug monitoring may be of assistance in detecting alterations in carbamazepine plasma concentrations. (نشرة سيفيكسيم، التداخلات الدوائية)

Examples Cyclosporine A, trimethoprim/sulfamethoxazole, bile acid sequestrants (cholestyramine), rifampin as well as aminoglycoside, cephalosporin, fluoroquinolone and penicillin classes of antimicrobials Drugs Modulating Glucuronidation Clinical Impact Concomitant use with drugs inducing glucuronidation decreases MPA systemic exposure, potentially reducing mycophenolate… (نشرة ميكوفينولات، التداخلات الدوائية)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Those at risk include patients with renal or hepatic impairment, or poor nutritional state, as well as patients receiving a protracted course of antimicrobial therapy, and patients previously stabilized on anticoagulant therapy. (نشرة سيفيكسيم، التحذيرات والاحتياطات)

Before initiating therapy with Meropenem for injection, it is important to inquire about previous hypersensitivity reactions to penicillins, cephalosporins, other β-lactams, and other allergens. (نشرة ميروبينيم، التحذيرات والاحتياطات)

Drug/Laboratory Test Interactions A false-positive reaction for ketones in the urine may occur with tests using nitroprusside but not with those using nitroferricyanide. (نشرة سيفيكسيم، التداخلات الدوائية)